To further investigate the impact of harboring DNMT3A CHIP-driver mutations on diffuse cardiac fibrosis in humans, we determined cardiac fibrosis using cardiac magnetic resonance imaging with myocardial mapping36–38 in patients with heart failure (Fig. 5a, Supplementary Table 2). This evidence concerns the gene STUB1 and heart failure.